profil


Institut Mérieux is contributing its experience in biology to improve medicine and public health across the globe.

To fight against infectious diseases and cancer, the Institute imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety, and nutrition.

Its three bio-industrial companies (bioMérieux, Transgene and Mérieux NutriSciences), working closely with its entities devoted to innovation (such as ABL Inc. and Mérieux Développement), have contributed to major advances in medicine and public health.

Institut Mérieux employs nearly 20,000 people around the world and is present in nearly 45 countries, with almost 3,2 billion euros in sales.

Institut Mérieux

family-owned holding company

5

companies working on public health all over the world

Lyon (France)

Areas of activity

in vitro diagnostics, immunotherapy, food safety, nutrition

Established in nearly

45

countries

20,000

employees

picto5

2019 sales

almost

3,2 billion

euros

picto2

12%

of sales invested in R&D